Fox Chase’s John A. “Drew” Ridge Is President of the American Radium Society

John Ridge, MD, PhD, FACS
John A. “Drew” Ridge, MD, PhD, FACS,

PHILADELPHIA (April 7, 2016) — John A. “Drew” Ridge, MD, PhD, FACS, President of the Medical Staff at Fox Chase Cancer Center, is the current President of the American Radium Society.

Ridge, chief of Head and Neck Surgery and the Louis Della Penna Family Chair in Head and Neck Oncology at Fox Chase, has also served as co-chair of the National Cancer Institute Head and Neck Steering Committee, a Governor of the American College of Surgeons, and President of the American Head and Neck Society. In addition, he has held leadership positions in the Eastern Cooperative Oncology Group (ECOG) and NRG Oncology cooperative groups.

Founded in 1916, the American Radium Society is the oldest academic group devoted to the study and treatment of cancer. As a multidisciplinary organization, members include radiation, surgical, gynecologic and medical oncologists. The meeting for the Society’s 100th Anniversary will be held in Philadelphia this month. More information about the organization and this year’s meeting can be found at www.americanradiumsociety.org.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text